Related Experiment Videos
Homologous monocuspid valve patch in right ventricular outflow tract reconstruction
1Department of Thoracic and Cardiovascular Surgery, Samsung Seoul Hospital, Sungkyunkwan University, School of Medicine, Seoul, Korea.
The Journal of Cardiovascular Surgery
|April 9, 2001
Summary
The homograft monocuspid valve patch effectively prevents pulmonary insufficiency after tetralogy of Fallot repair, showing excellent early results in pediatric patients. Long-term durability requires further investigation.
Area of Science:
- Cardiovascular Surgery
- Pediatric Cardiology
- Biomaterials in Medicine
Background:
- Pulmonary regurgitation poses risks in postoperative tetralogy of Fallot and pulmonary atresia repair.
- A homograft monocuspid valve patch was utilized to mitigate pulmonary insufficiency.
Purpose of the Study:
- To evaluate the efficacy of a homograft monocuspid valve patch in preventing pulmonary insufficiency.
- To assess the functional outcomes of this surgical technique in pediatric patients.
Main Methods:
- Twenty-five pediatric patients (4 months to 8 years) underwent right ventricular outflow tract reconstruction using a homograft monocuspid valve.
- Echocardiography was employed to assess valve function and pulmonary insufficiency at various postoperative intervals (pre-discharge, 3-6 months, 12 months).
Main Results:
- 88% of patients demonstrated no significant pulmonary insufficiency on echocardiogram before discharge.
- At 3-6 months, 81% maintained no significant pulmonary insufficiency.
- No patients with over 1 year of follow-up developed newly significant pulmonary insufficiency.
Conclusions:
- The homograft monocuspid valve patch shows excellent early efficacy in preventing pulmonary insufficiency.
- While early results are promising, the long-term durability necessitates continued close patient monitoring.